College of Pharmacists of British Columbia
Published on College of Pharmacists of British Columbia (https://www.bcpharmacists.org)

Home > Resources > Archived Bylaws and Professional Practice Policies

Share
Facebook Twitter LinkedIn

Archived Bylaws and Professional Practice Policies

Archived Bylaws

HPA Bylaws
Bylaws
  • Schedule A - Code of Ethics
    • Code of Ethics - Summary of Standards
    • Code of Ethics - Detailed
    • Conflict of Interest Standards
    • Model for Ethical Decision Making
    • Patient Relations Program Standard
    • Pharmacy Oath
  • Schedule B - Electoral Districts
  • Schedule C - Recognized Education Programs
  • Schedule D - Fee Schedule
  • Schedule E - Tariff of Costs
  • Schedule F - Standards of Practice
    • Part 1 - Community Pharmacy
    • Part 2 - Hospital Pharmacy
    • Part 3 - Residential Care Facilities and Homes
    • Part 4 - Drug Administration by Injection and Intranasal Route
    • Part 5 - Dispensing Drugs for the Purpose of Medical Assistance in Dying
    • Part 6 - Telepharmacy
    • Part 7 - Indigenous Cultural Safety, Humility, and Anti-racism Practice Standard
    • Part 8 - Making a Diagnosis and Prescribing
    • Part 9 - Ordering, Receiving, and Interpreting Laboratory Tests  Standards, Limits and Conditions
  • Schedule G - Maximum Fees of the Freedom of Information and Protection of Privacy Act
PODSA Bylaws
  • Bylaws
    • Schedule A - Fee Schedule
    • Schedule B - Exemptions to Act
    • Schedule F - Telepharmacy and Community Licenced Sites
    • Schedule G - Telepharmacy Staff Exempted Sites
    • Schedule H - Telepharmacy Rural and Remote Communities

Archived Professional Practice Policies and Guides

 

Professional Practice Policies (Full Document)

GENERAL PHARMACY PRACTICE
  • PPP-3 Pharmacy References
  • PPP-58 Adapting a Prescription
  • PPP-59 Pharmacy Equipment
  • PPP-60 Professional Liability Insurance
  • PPP-64 Guidelines to Pharmacy Compounding
  • PPP-65 Narcotic Counts and Reconciliations
  • PPP-68 Cold Chain Management
  • PPP-70 Making a Diagnosis and Prescribing - Regulatory Education Module
  • PPP-73 Validate Identification and Verify College Registration Status for New and Existing Registrant Staff
  • PPP-75 Patient Identification
  • PPP-76 Criminal Record History Vendor
  • PPP-77 Signage within the Pharmacy (Expectations of Care Poster)
COMMUNITY PHARMACY
  • PPP-15 Controlled Drug Substances Signing Authorizations
  • PPP-24 Depot Shipments of Prescriptions
  • PPP-31 Emergency Supply for Continuity of Care
  • PPP-43 Automated Pharmacy Dispensing System
  • PPP-46 Temporary Pharmacy Closures
  • PPP-50 Centralized Prescription Processing
  • PPP-54 Identifying Patients and Patient Representatives in Community Pharmacy and Telepharmacy Settings
  • PPP-64 Guidelines to Pharmacy Compounding
  • PPP-66 Opioid Agonist Treatment
  • PPP-67 Injectable Opioid Agonist Treatment
  • PPP-69 Community Pharmacy Manager Education
  • PPP-71 Delivery of Opioid Agonist Treatment
  • PPP-74 Community Pharmacy and Telepharmacy Security
  • PPP-76 Criminal Record History Vendor
  • PPP-77 Signage within the Pharmacy (Expectations of Care Poster)
HOSPITAL PHARMACY
  • PPP-15 Narcotic and Controlled Drug Signing Authorizations
  • PPP-27 Registration Requirements for Pharm.D. Program Students
  • PPP-43 Automated Pharmacy Dispensing System
  • PPP-56 Standards for Pharmacy Assistant Verification of Non-Sterile Products in Hospital Pharmacy Practice
  • PPP-57 Standards for Pharmacy Assistant Verification of Sterile Products in Hospital Pharmacy Practice
  • PPP-63 Hospital Pharmacist Role with Respect to Drug Distribution Systems, Drug Administration Devices, Products and Services
  • PPP-64 Guidelines to Pharmacy Compounding
  • PPP-76 Criminal Record History Vendor
  • PPP-77 Signage within the Pharmacy (Expectations of Care Poster)

 

Guides and additional Resources

PPP-58 Adapting a Prescription:

  • Additional Resources

PPP-66 Opioid Agonist Treatment:

  • PPP-66 Policy Guide: Buprenorphine/Naloxone Maintenance Treatment (2018)

  • PPP-66 Policy Guide: Methadone Maintenance Treatment (2013)

  • PPP-66 Policy Guide: Slow Release Oral Morphine Maintenance (SROM) Treatment (2018)

PPP-67 Injectable Opioid Agonist Treatment 

  • PPP-67 Policy Guide: Injectable Hydromorphone Maintenance Treatment (2018)

Source URL:https://www.bcpharmacists.org/archived-bylaws-professional-practice-policies